Russell L. Margolis, MD/PhD - Publications

Affiliations: 
Psychiatry and Behavioral Sciences Johns Hopkins University, Baltimore, MD 
Website:
http://www.hopkinsmedicine.org/psychiatry/expert_team/faculty/M/Margolis.html

150 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Li PP, Sun X, Xia G, Arbez N, Paul S, Zhu S, Peng HB, Ross CA, Koeppen AH, Margolis RL, Pulst SM, Ashizawa T, Rudnicki DD. ATXN2-AS, a gene antisense to ATXN2, is associated with SCA2 and ALS. Annals of Neurology. PMID 27531668 DOI: 10.1002/ana.24761  0.48
2016 Frank S, Testa CM, Stamler D, Kayson E, Davis C, Edmondson MC, Kinel S, Leavitt B, Oakes D, O'Neill C, Vaughan C, Goldstein J, Herzog M, Snively V, ... ... Margolis RL, et al. Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial. Jama. 316: 40-50. PMID 27380342 DOI: 10.1001/jama.2016.8655  0.48
2016 Brandt AS, Unschuld PG, Pradhan S, Lim IA, Churchill G, Harris AD, Hua J, Barker PB, Ross CA, van Zijl PC, Edden RA, Margolis RL. Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A (1)H MRS Study at 7Tesla. Schizophrenia Research. PMID 26925800 DOI: 10.1016/j.schres.2016.02.017  0.48
2015 Bañez-Coronel M, Ayhan F, Tarabochia AD, Zu T, Perez BA, Tusi SK, Pletnikova O, Borchelt DR, Ross CA, Margolis RL, Yachnis AT, Troncoso JC, Ranum LP. RAN Translation in Huntington Disease. Neuron. 88: 667-77. PMID 26590344 DOI: 10.1016/j.neuron.2015.10.038  0.48
2015 O'Hearn EE, Hwang HS, Holmes SE, Rudnicki DD, Chung DW, Seixas AI, Cohen RL, Ross CA, Trojanowski JQ, Pletnikova O, Troncoso JC, Margolis RL. Neuropathology and Cellular Pathogenesis of Spinocerebellar Ataxia Type 12. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26340331 DOI: 10.1002/mds.26348  0.48
2015 Sun X, Li PP, Zhu S, Cohen R, Marque LO, Ross CA, Pulst SM, Chan HY, Margolis RL, Rudnicki DD. Nuclear retention of full-length HTT RNA is mediated by splicing factors MBNL1 and U2AF65. Scientific Reports. 5: 12521. PMID 26218986 DOI: 10.1038/srep12521  0.48
2015 Krause A, Mitchell C, Essop F, Tager S, Temlett J, Stevanin G, Ross C, Rudnicki D, Margolis R. Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. PMID 26079385 DOI: 10.1002/ajmg.b.32332  0.48
2015 Angus D, Herd C, Stone C, Stout J, Wieler M, Reilmann R, Ritchie CW, Dorsey ER, Helles K, Kayson E, Oakes D, Rosas HD, Vaughan C, Panegyres PK, Ames D, ... ... Margolis R, et al. Safety, tolerability, and efficacy of PBT2 in Huntington's disease: A phase 2, randomised, double-blind, placebo-controlled trial The Lancet Neurology. 14: 39-47. PMID 25467848 DOI: 10.1016/S1474-4422(14)70262-5  0.48
2014 Wen Z, Nguyen HN, Guo Z, Lalli MA, Wang X, Su Y, Kim NS, Yoon KJ, Shin J, Zhang C, Makri G, Nauen D, Yu H, Guzman E, Chiang CH, ... ... Margolis RL, et al. Synaptic dysregulation in a human iPS cell model of mental disorders. Nature. 515: 414-8. PMID 25132547 DOI: 10.1038/nature13716  0.48
2014 Margolis RL. Tetrabenazine, depression and suicide: good news. Journal of Huntington's Disease. 3: 137-8. PMID 25062856 DOI: 10.3233/JHD-140107  0.48
2014 Sun X, Marque LO, Cordner Z, Pruitt JL, Bhat M, Li PP, Kannan G, Ladenheim EE, Moran TH, Margolis RL, Rudnicki DD. Phosphorodiamidate morpholino oligomers suppress mutant huntingtin expression and attenuate neurotoxicity. Human Molecular Genetics. 23: 6302-17. PMID 25035419 DOI: 10.1093/hmg/ddu349  0.48
2014 Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, Scahill RI, Leavitt BR, Stout JC, Paulsen JS, Reilmann R, Unschuld PG, Wexler A, Margolis RL, Tabrizi SJ. Huntington disease: natural history, biomarkers and prospects for therapeutics. Nature Reviews. Neurology. 10: 204-16. PMID 24614516 DOI: 10.1038/nrneurol.2014.24  0.48
2014 Hua J, Unschuld PG, Margolis RL, van Zijl PC, Ross CA. Elevated arteriolar cerebral blood volume in prodromal Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 396-401. PMID 23847161 DOI: 10.1002/mds.25591  0.48
2014 Yu L, Arbez N, Nucifora LG, Sell GL, Delisi LE, Ross CA, Margolis RL, Nucifora FC. A mutation in NPAS3 segregates with mental illness in a small family. Molecular Psychiatry. 19: 7-8. PMID 23337948 DOI: 10.1038/mp.2012.192  0.48
2014 Younes L, Ratnanather JT, Brown T, Aylward E, Nopoulos P, Johnson H, Magnotta VA, Paulsen JS, Margolis RL, Albin RL, Miller MI, Ross CA. Regionally selective atrophy of subcortical structures in prodromal HD as revealed by statistical shape analysis. Human Brain Mapping. 35: 792-809. PMID 23281100 DOI: 10.1002/hbm.22214  0.48
2014 Rudnicki DD, Yang XW, Margolis RL. HDL2 Mouse Movement Disorders: Genetics and Models: Second Edition. 573-582. DOI: 10.1016/B978-0-12-405195-9.00034-2  0.48
2013 Calleo J, Williams JR, Amspoker AB, Swearingen L, Hirsch ES, Anderson K, Goldstein SR, Grill S, Lehmann S, Little JT, Margolis RL, Palanci J, Pontone GM, Weiss H, Rabins P, et al. Application of depression rating scales in patients with Parkinson's disease with and without co-Occurring anxiety. Journal of Parkinson's Disease. 3: 603-8. PMID 24275604 DOI: 10.3233/JPD-130264  0.48
2013 Unschuld PG, Liu X, Shanahan M, Margolis RL, Bassett SS, Brandt J, Schretlen DJ, Redgrave GW, Hua J, Hock C, Reading SA, van Zijl PC, Pekar JJ, Ross CA. Prefrontal executive function associated coupling relates to Huntington's disease stage. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 49: 2661-73. PMID 23906595 DOI: 10.1016/j.cortex.2013.05.015  0.48
2013 Ramos EM, Latourelle JC, Gillis T, Mysore JS, Squitieri F, Di Pardo A, Di Donato S, Gellera C, Hayden MR, Morrison PJ, Nance M, Ross CA, Margolis RL, Gomez-Tortosa E, Ayuso C, et al. Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset. Neurogenetics. 14: 173-9. PMID 23644918 DOI: 10.1007/s10048-013-0364-y  0.48
2013 Pontone GM, Williams JR, Anderson KE, Chase G, Goldstein SR, Grill S, Hirsch ES, Lehmann S, Little JT, Margolis RL, Palanci J, Rabins PV, Weiss HD, Marsh L. Pharmacologic treatment of anxiety disorders in Parkinson disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 21: 520-8. PMID 23567419 DOI: 10.1016/j.jagp.2012.10.023  0.48
2012 Cloud LJ, Rosenblatt A, Margolis RL, Ross CA, Pillai JA, Corey-Bloom J, Tully HM, Bird T, Panegyres PK, Nichter CA, Higgins DS, Helmers SL, Factor SA, Jones R, Testa CM. Seizures in juvenile Huntington's disease: frequency and characterization in a multicenter cohort. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1797-800. PMID 23124580 DOI: 10.1002/mds.25237  0.48
2012 Guo Z, Rudow G, Pletnikova O, Codispoti KE, Orr BA, Crain BJ, Duan W, Margolis RL, Rosenblatt A, Ross CA, Troncoso JC. Striatal neuronal loss correlates with clinical motor impairment in Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1379-86. PMID 22975850 DOI: 10.1002/mds.25159  0.48
2012 Unschuld PG, Joel SE, Pekar JJ, Reading SA, Oishi K, McEntee J, Shanahan M, Bakker A, Margolis RL, Bassett SS, Rosenblatt A, Mori S, van Zijl PC, Ross CA, Redgrave GW. Depressive symptoms in prodromal Huntington's Disease correlate with Stroop-interference related functional connectivity in the ventromedial prefrontal cortex. Psychiatry Research. 203: 166-74. PMID 22974690 DOI: 10.1016/j.pscychresns.2012.01.002  0.48
2012 Ramos EM, Latourelle JC, Lee JH, Gillis T, Mysore JS, Squitieri F, Di Pardo A, Di Donato S, Hayden MR, Morrison PJ, Nance M, Ross CA, Margolis RL, Gomez-Tortosa E, Ayuso C, et al. Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onset. Human Genetics. 131: 1833-40. PMID 22825315 DOI: 10.1007/s00439-012-1205-z  0.48
2012 Lee JH, Lee JM, Ramos EM, Gillis T, Mysore JS, Kishikawa S, Hadzi T, Hendricks AE, Hayden MR, Morrison PJ, Nance M, Ross CA, Margolis RL, Squitieri F, Gellera C, et al. TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease. Biochemical and Biophysical Research Communications. 424: 404-8. PMID 22771793 DOI: 10.1016/j.bbrc.2012.06.120  0.48
2012 Unschuld PG, Edden RA, Carass A, Liu X, Shanahan M, Wang X, Oishi K, Brandt J, Bassett SS, Redgrave GW, Margolis RL, van Zijl PC, Barker PB, Ross CA. Brain metabolite alterations and cognitive dysfunction in early Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 895-902. PMID 22649062 DOI: 10.1002/mds.25010  0.48
2012 Juopperi TA, Kim WR, Chiang CH, Yu H, Margolis RL, Ross CA, Ming GL, Song H. Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells. Molecular Brain. 5: 17. PMID 22613578 DOI: 10.1186/1756-6606-5-17  0.48
2012 Prohaska R, Sibon OC, Rudnicki DD, Danek A, Hayflick SJ, Verhaag EM, Vonk JJ, Margolis RL, Walker RH. Brain, blood, and iron: perspectives on the roles of erythrocytes and iron in neurodegeneration. Neurobiology of Disease. 46: 607-24. PMID 22426390 DOI: 10.1016/j.nbd.2012.03.006  0.48
2012 Unschuld PG, Joel SE, Liu X, Shanahan M, Margolis RL, Biglan KM, Bassett SS, Schretlen DJ, Redgrave GW, van Zijl PC, Pekar JJ, Ross CA. Impaired cortico-striatal functional connectivity in prodromal Huntington's Disease. Neuroscience Letters. 514: 204-9. PMID 22425717 DOI: 10.1016/j.neulet.2012.02.095  0.48
2012 Williams JR, Hirsch ES, Anderson K, Bush AL, Goldstein SR, Grill S, Lehmann S, Little JT, Margolis RL, Palanci J, Pontone G, Weiss H, Rabins P, Marsh L. A comparison of nine scales to detect depression in Parkinson disease: which scale to use? Neurology. 78: 998-1006. PMID 22422897 DOI: 10.1212/WNL.0b013e31824d587f  0.48
2012 Lee JM, Gillis T, Mysore JS, Ramos EM, Myers RH, Hayden MR, Morrison PJ, Nance M, Ross CA, Margolis RL, Squitieri F, Griguoli A, Di Donato S, Gomez-Tortosa E, Ayuso C, et al. Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene region. American Journal of Human Genetics. 90: 434-44. PMID 22387017 DOI: 10.1016/j.ajhg.2012.01.005  0.48
2012 Rudnicki DD, Margolis RL, Pearson CE, Krzyzosiak WJ. Diced triplets expose neurons to RISC. Plos Genetics. 8: e1002545. PMID 22383898 DOI: 10.1371/journal.pgen.1002545  0.48
2012 Seixas AI, Holmes SE, Takeshima H, Pavlovich A, Sachs N, Pruitt JL, Silveira I, Ross CA, Margolis RL, Rudnicki DD. Loss of junctophilin-3 contributes to Huntington disease-like 2 pathogenesis. Annals of Neurology. 71: 245-57. PMID 22367996 DOI: 10.1002/ana.22598  0.48
2012 Lee JM, Ramos EM, Lee JH, Gillis T, Mysore JS, Hayden MR, Warby SC, Morrison P, Nance M, Ross CA, Margolis RL, Squitieri F, Orobello S, Di Donato S, Gomez-Tortosa E, et al. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology. 78: 690-5. PMID 22323755 DOI: 10.1212/WNL.0b013e318249f683  0.48
2012 Rosenblatt A, Kumar BV, Mo A, Welsh CS, Margolis RL, Ross CA. Age, CAG repeat length, and clinical progression in Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 272-6. PMID 22173986 DOI: 10.1002/mds.24024  0.48
2012 O'Hearn E, Holmes SE, Margolis RL. Spinocerebellar ataxia type 12. Handbook of Clinical Neurology. 103: 535-47. PMID 21827912 DOI: 10.1016/B978-0-444-51892-7.00034-6  0.48
2012 Mack J, Rabins P, Anderson K, Goldstein S, Grill S, Hirsch ES, Lehmann S, Little JT, Margolis RL, Palanci J, Pontone G, Weiss H, Williams JR, Marsh L. Prevalence of psychotic symptoms in a community-based Parkinson disease sample. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 20: 123-32. PMID 21617521 DOI: 10.1097/JGP.0b013e31821f1b41  0.48
2011 Chung DW, Rudnicki DD, Yu L, Margolis RL. A natural antisense transcript at the Huntington's disease repeat locus regulates HTT expression. Human Molecular Genetics. 20: 3467-77. PMID 21672921 DOI: 10.1093/hmg/ddr263  0.48
2011 Nagata E, Saiardi A, Tsukamoto H, Okada Y, Itoh Y, Satoh T, Itoh J, Margolis RL, Takizawa S, Sawa A, Takagi S. Inositol hexakisphosphate kinases induce cell death in Huntington disease. The Journal of Biological Chemistry. 286: 26680-6. PMID 21652713 DOI: 10.1074/jbc.M111.220749  0.48
2011 Seixas AI, Vale J, Jorge P, Marques I, Santos R, Alonso I, Fortuna AM, Pinto-Basto J, Coutinho P, Margolis RL, Sequeiros J, Silveira I. FXTAS is rare among Portuguese patients with movement disorders: FMR1 premutations may be associated with a wider spectrum of phenotypes. Behavioral and Brain Functions : Bbf. 7: 19. PMID 21639881 DOI: 10.1186/1744-9081-7-19  0.48
2011 Wilburn B, Rudnicki DD, Zhao J, Weitz TM, Cheng Y, Gu X, Greiner E, Park CS, Wang N, Sopher BL, La Spada AR, Osmand A, Margolis RL, Sun YE, Yang XW. An antisense CAG repeat transcript at JPH3 locus mediates expanded polyglutamine protein toxicity in Huntington's disease-like 2 mice. Neuron. 70: 427-40. PMID 21555070 DOI: 10.1016/j.neuron.2011.03.021  0.48
2011 Rosenblatt A, Kumar BV, Margolis RL, Welsh CS, Ross CA. Factors contributing to institutionalization in patients with Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 1711-6. PMID 21538527 DOI: 10.1002/mds.23716  0.48
2011 Chiang CH, Su Y, Wen Z, Yoritomo N, Ross CA, Margolis RL, Song H, Ming GL. Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation. Molecular Psychiatry. 16: 358-60. PMID 21339753 DOI: 10.1038/mp.2011.13  0.48
2011 Pontone GM, Williams JR, Anderson KE, Chase G, Goldstein SR, Grill S, Hirsch ES, Lehmann S, Little JT, Margolis RL, Rabins PV, Weiss HD, Marsh L. Anxiety and self-perceived health status in Parkinson's disease. Parkinsonism & Related Disorders. 17: 249-54. PMID 21292531 DOI: 10.1016/j.parkreldis.2011.01.005  0.48
2011 Ayhan Y, Abazyan B, Nomura J, Kim R, Ladenheim B, Krasnova IN, Sawa A, Margolis RL, Cadet JL, Mori S, Vogel MW, Ross CA, Pletnikov MV. Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders. Molecular Psychiatry. 16: 293-306. PMID 20048751 DOI: 10.1038/mp.2009.144  0.48
2010 Cagnoli C, Stevanin G, Brussino A, Barberis M, Mancini C, Margolis RL, Holmes SE, Nobili M, Forlani S, Padovan S, Pappi P, Zaros C, Leber I, Ribai P, Pugliese L, et al. Missense mutations in the AFG3L2 proteolytic domain account for ∼1.5% of European autosomal dominant cerebellar ataxias. Human Mutation. 31: 1117-24. PMID 20725928 DOI: 10.1002/humu.21342  0.48
2010 Margolis RL, Ross CA. Neuronal signaling pathways: genetic insights into the pathophysiology of major mental illness. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 350-1. PMID 20010716 DOI: 10.1038/npp.2009.137  0.48
2009 Bruce HA, Sachs N, Rudnicki DD, Lin SG, Willour VL, Cowell JK, Conroy J, McQuaid DE, Rossi M, Gaile DP, Nowak NJ, Holmes SE, Sklar P, Ross CA, Delisi LE, ... Margolis RL, et al. Long tandem repeats as a form of genomic copy number variation: structure and length polymorphism of a chromosome 5p repeat in control and schizophrenia populations. Psychiatric Genetics. 19: 64-71. PMID 19672138 DOI: 10.1097/YPG.0b013e3283207ff6  0.48
2009 Margolis RL. Neuropsychiatric disorders: The choice of antipsychotics in schizophrenia. Nature Reviews. Neurology. 5: 308-10. PMID 19498434 DOI: 10.1038/nrneurol.2009.68  0.48
2009 Pontone GM, Williams JR, Anderson KE, Chase G, Goldstein SA, Grill S, Hirsch ES, Lehmann S, Little JT, Margolis RL, Rabins PV, Weiss HD, Marsh L. Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 1333-8. PMID 19425086 DOI: 10.1002/mds.22611  0.48
2009 Ross CA, Margolis RL. Schizophrenia: A point of disruption. Nature. 458: 976-7. PMID 19396131 DOI: 10.1038/458976a  0.48
2008 Brandt J, Inscore AB, Ward J, Shpritz B, Rosenblatt A, Margolis RL, Ross CA. Neuropsychological deficits in Huntington's disease gene carriers and correlates of early "conversion". The Journal of Neuropsychiatry and Clinical Neurosciences. 20: 466-72. PMID 19196932 DOI: 10.1176/appi.neuropsych.20.4.466  0.48
2008 Rottnek M, Riggio S, Byne W, Sano M, Margolis RL, Walker RH. Schizophrenia in a patient with spinocerebellar ataxia 2: coincidence of two disorders or a neurodegenerative disease presenting with psychosis? The American Journal of Psychiatry. 165: 964-7. PMID 18676601 DOI: 10.1176/appi.ajp.2008.08020285  0.48
2008 Rudnicki DD, Pletnikova O, Vonsattel JP, Ross CA, Margolis RL. A comparison of huntington disease and huntington disease-like 2 neuropathology. Journal of Neuropathology and Experimental Neurology. 67: 366-74. PMID 18379432 DOI: 10.1097/NEN.0b013e31816b4aee  0.48
2007 Greenstein PE, Vonsattel JP, Margolis RL, Joseph JT. Huntington's disease like-2 neuropathology. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 1416-23. PMID 17516481 DOI: 10.1002/mds.21417  0.48
2007 Rudnicki DD, Holmes SE, Lin MW, Thornton CA, Ross CA, Margolis RL. Huntington's disease--like 2 is associated with CUG repeat-containing RNA foci. Annals of Neurology. 61: 272-82. PMID 17387722 DOI: 10.1002/ana.21081  0.48
2007 Andresen JM, Gayán J, Djoussé L, Roberts S, Brocklebank D, Cherny SS, Cardon LR, Gusella JF, MacDonald ME, Myers RH, Housman DE, Wexler NS. The relationship between CAG repeat length and age of onset differs for Huntington's disease patients with juvenile onset or adult onset. Annals of Human Genetics. 71: 295-301. PMID 17181545 DOI: 10.1111/j.1469-1809.2006.00335.x  0.48
2007 Ross CA, Margolis RL, Reading SAJ, Pletnikov M, Coyle JT. Neurobiology of schizophrenia | Neurobiologia schizofrenii Wiadomosci Psychiatryczne. 10: 195-215.  0.48
2006 Ross CA, Margolis RL, Reading SA, Pletnikov M, Coyle JT. Neurobiology of schizophrenia. Neuron. 52: 139-53. PMID 17015232 DOI: 10.1016/j.neuron.2006.09.015  0.48
2006 Ward J, Sheppard JM, Shpritz B, Margolis RL, Rosenblatt A, Brandt J. A four-year prospective study of cognitive functioning in Huntington's disease. Journal of the International Neuropsychological Society : Jins. 12: 445-54. PMID 16981596 DOI: 10.1017/S1355617706060747  0.48
2006 Li JL, Hayden MR, Warby SC, Durr A, Morrison PJ, Nance M, Ross CA, Margolis RL, Rosenblatt A, Squitieri F, Frati L, Gómez-Tortosa E, García CA, Suchowersky O, Klimek ML, et al. Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23-24: the HD MAPS study. Bmc Medical Genetics. 7: 71. PMID 16914060 DOI: 10.1186/1471-2350-7-71  0.48
2006 Holmes SE, Wentzell JS, Seixas AI, Callahan C, Silveira I, Ross CA, Margolis RL. A novel trinucleotide repeat expansion at chromosome 3q26.2 identified by a CAG/CTG repeat expansion detection array. Human Genetics. 120: 193-200. PMID 16783570 DOI: 10.1007/s00439-006-0207-0  0.48
2006 Rosenblatt A, Liang KY, Zhou H, Abbott MH, Gourley LM, Margolis RL, Brandt J, Ross CA. The association of CAG repeat length with clinical progression in Huntington disease. Neurology. 66: 1016-20. PMID 16606912 DOI: 10.1212/01.wnl.0000204230.16619.d9  0.48
2006 Holmes SE, O'Hearn E, Cortez-Apreza N, Hwang HS, Ross CA, Strack S, Margolis RL. Spinocerebellar ataxia type 12 Genetic Instabilities and Neurological Diseases, Second Edition. 461-473. DOI: 10.1016/B978-012369462-1/50032-6  0.48
2005 Reading SA, Yassa MA, Bakker A, Dziorny AC, Gourley LM, Yallapragada V, Rosenblatt A, Margolis RL, Aylward EH, Brandt J, Mori S, van Zijl P, Bassett SS, Ross CA. Regional white matter change in pre-symptomatic Huntington's disease: a diffusion tensor imaging study. Psychiatry Research. 140: 55-62. PMID 16199141 DOI: 10.1016/j.pscychresns.2005.05.011  0.48
2005 Bahl S, Virdi K, Mittal U, Sachdeva MP, Kalla AK, Holmes SE, O'Hearn E, Margolis RL, Jain S, Srivastava AK, Mukerji M. Evidence of a common founder for SCA12 in the Indian population. Annals of Human Genetics. 69: 528-34. PMID 16138911 DOI: 10.1046/j.1529-8817.2005.00173.x  0.48
2005 Smith WW, Margolis RL, Li X, Troncoso JC, Lee MK, Dawson VL, Dawson TM, Iwatsubo T, Ross CA. Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 5544-52. PMID 15944382 DOI: 10.1523/JNEUROSCI.0482-05.2005  0.48
2005 Sachs NA, Sawa A, Holmes SE, Ross CA, DeLisi LE, Margolis RL. A frameshift mutation in Disrupted in Schizophrenia 1 in an American family with schizophrenia and schizoaffective disorder. Molecular Psychiatry. 10: 758-64. PMID 15940305 DOI: 10.1038/sj.mp.4001667  0.48
2005 Seixas AI, Maurer MH, Lin M, Callahan C, Ahuja A, Matsuura T, Ross CA, Hisama FM, Silveira I, Margolis RL. FXTAS, SCA10, and SCA17 in American patients with movement disorders. American Journal of Medical Genetics. Part A. 136: 87-9. PMID 15889413 DOI: 10.1002/ajmg.a.30761  0.48
2005 Margolis RL, Rudnicki DD, Holmes SE. Huntington's disease like-2: review and update. Acta Neurologica Taiwanica. 14: 1-8. PMID 15835282  0.48
2005 Chen DH, Cimino PJ, Ranum LP, Zoghbi HY, Yabe I, Schut L, Margolis RL, Lipe HP, Feleke A, Matsushita M, Wolff J, Morgan C, Lau D, Fernandez M, Sasaki H, et al. The clinical and genetic spectrum of spinocerebellar ataxia 14. Neurology. 64: 1258-60. PMID 15824357 DOI: 10.1212/01.WNL.0000156801.64549.6B  0.48
2005 Ross CA, Margolis RL. Neurogenetics: Insights into degenerative diseases and approaches to schizophrenia Clinical Neuroscience Research. 5: 3-14. DOI: 10.1016/j.cnr.2005.07.001  0.48
2004 Margolis RL, Holmes SE, Rosenblatt A, Gourley L, O'Hearn E, Ross CA, Seltzer WK, Walker RH, Ashizawa T, Rasmussen A, Hayden M, Almqvist EW, Harris J, Fahn S, MacDonald ME, et al. Huntington's Disease-like 2 (HDL2) in North America and Japan. Annals of Neurology. 56: 670-4. PMID 15468075 DOI: 10.1002/ana.20248  0.48
2004 Saiki S, Sakai K, Saiki M, Hirose G, Walker RH, Margolis RL. Huntington's disease-like 2 can present as chorea-acanthocytosis [2] (multiple letters) Neurology. 63: 939-940. PMID 15365163  0.48
2004 Brandt J, Leroi I, O'Hearn E, Rosenblatt A, Margolis RL. Cognitive impairments in cerebellar degeneration: a comparison with Huntington's disease. The Journal of Neuropsychiatry and Clinical Neurosciences. 16: 176-84. PMID 15260369 DOI: 10.1176/appi.neuropsych.16.2.176  0.48
2004 Aylward EH, Sparks BF, Field KM, Yallapragada V, Shpritz BD, Rosenblatt A, Brandt J, Gourley LM, Liang K, Zhou H, Margolis RL, Ross CA. Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology. 63: 66-72. PMID 15249612  0.48
2004 Nicholas AP, O'Hearn E, Holmes SE, Chen DT, Margolis RL. Clinical signs and symptoms in a large hereditary spastic paraparesis pedigree with a novel spastin mutation. Movement Disorders : Official Journal of the Movement Disorder Society. 19: 641-8. PMID 15197701 DOI: 10.1002/mds.20077  0.48
2004 Reading SA, Dziorny AC, Peroutka LA, Schreiber M, Gourley LM, Yallapragada V, Rosenblatt A, Margolis RL, Pekar JJ, Pearlson GD, Aylward E, Brandt J, Bassett SS, Ross CA. Functional brain changes in presymptomatic Huntington's disease. Annals of Neurology. 55: 879-83. PMID 15174024 DOI: 10.1002/ana.20121  0.48
2004 Cagnoli C, Michielotto C, Matsuura T, Ashizawa T, Margolis RL, Holmes SE, Gellera C, Migone N, Brusco A. Detection of large pathogenic expansions in FRDA1, SCA10, and SCA12 genes using a simple fluorescent repeat-primed PCR assay. The Journal of Molecular Diagnostics : Jmd. 6: 96-100. PMID 15096564 DOI: 10.1016/S1525-1578(10)60496-5  0.48
2004 Djoussé L, Knowlton B, Hayden MR, Almqvist EW, Brinkman RR, Ross CA, Margolis RL, Rosenblatt A, Durr A, Dode C, Morrison PJ, Novelletto A, Frontali M, Trent RJ, McCusker E, et al. Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16. Neurogenetics. 5: 109-14. PMID 15029481 DOI: 10.1007/s10048-004-0175-2  0.48
2004 Liszewski CM, O'Hearn E, Leroi I, Gourley L, Ross CA, Margolis RL. Cognitive impairment and psychiatric symptoms in 133 patients with diseases associated with cerebellar degeneration. The Journal of Neuropsychiatry and Clinical Neurosciences. 16: 109-12. PMID 14990766 DOI: 10.1176/appi.neuropsych.16.1.109  0.48
2004 Tsutsumi T, Holmes SE, McInnis MG, Sawa A, Callahan C, DePaulo JR, Ross CA, DeLisi LE, Margolis RL. Novel CAG/CTG repeat expansion mutations do not contribute to the genetic risk for most cases of bipolar disorder or schizophrenia. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 124: 15-9. PMID 14681907 DOI: 10.1002/ajmg.b.20058  0.48
2003 Walker RH, Jankovic J, O'Hearn E, Margolis RL. Phenotypic features of Huntington's disease-like 2. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 1527-30. PMID 14673892 DOI: 10.1002/mds.10587  0.48
2003 Margolis RL. Dominant spinocerebellar ataxias: a molecular approach to classification, diagnosis, pathogenesis and the future. Expert Review of Molecular Diagnostics. 3: 715-32. PMID 14628900 DOI: 10.1586/14737159.3.6.715  0.48
2003 Rudnicki DD, Margolis RL. Repeat expansion and autosomal dominant neurodegenerative disorders: consensus and controversy. Expert Reviews in Molecular Medicine. 5: 1-24. PMID 14585172 DOI: doi:10.1017/S1462399403006598  0.48
2003 Walker RH, Rasmussen A, Rudnicki D, Holmes SE, Alonso E, Matsuura T, Ashizawa T, Davidoff-Feldman B, Margolis RL. Huntington's disease--like 2 can present as chorea-acanthocytosis. Neurology. 61: 1002-4. PMID 14557581  0.48
2003 Holmes SE, O'Hearn E, Margolis RL. Why is SCA12 different from other SCAs? Cytogenetic and Genome Research. 100: 189-97. PMID 14526180 DOI: 10.1159/000072854  0.48
2003 Rosenblatt A, Abbott MH, Gourley LM, Troncoso JC, Margolis RL, Brandt J, Ross CA. Predictors of neuropathological severity in 100 patients with Huntington's disease. Annals of Neurology. 54: 488-93. PMID 14520661 DOI: 10.1002/ana.10691  0.48
2003 Margolis RL, Ross CA. Diagnosis of Huntington disease. Clinical Chemistry. 49: 1726-32. PMID 14500613 DOI: 10.1373/49.10.1726  0.48
2003 Li JL, Hayden MR, Almqvist EW, Brinkman RR, Durr A, Dodé C, Morrison PJ, Suchowersky O, Ross CA, Margolis RL, Rosenblatt A, Gómez-Tortosa E, Cabrero DM, Novelletto A, Frontali M, et al. A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS study. American Journal of Human Genetics. 73: 682-7. PMID 12900792 DOI: 10.1086/378133  0.48
2003 Djoussé L, Knowlton B, Hayden M, Almqvist EW, Brinkman R, Ross C, Margolis R, Rosenblatt A, Durr A, Dode C, Morrison PJ, Novelletto A, Frontali M, Trent RJ, McCusker E, et al. Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease. American Journal of Medical Genetics. Part A. 119: 279-82. PMID 12784292 DOI: 10.1002/ajmg.a.20190  0.48
2003 Margolis RL, Holmes SE. Huntington's disease-like 2: A clinical, pathological, and molecular comparison to Huntington's disease Clinical Neuroscience Research. 3: 187-196. DOI: 10.1016/S1566-2772(03)00061-6  0.48
2003 Holmes SE, O'Hearn E, Brahmachari SK, Choudhry S, Srivastava AK, Jain S, Ross CA, Margolis RL. Spinocerebellar Ataxia 12 (SCA12) Genetics of Movement Disorders. 121-132. DOI: 10.1016/B978-012566652-7/50015-0  0.48
2002 Brandt J, Shpritz B, Codori AM, Margolis R, Rosenbalt A. Neuropsychological manifestations of the genetic mutation for Huntington's disease in presymptomatic individuals Journal of the International Neuropsychological Society. 8: 918-924. PMID 12405543 DOI: 10.1017/S1355617702870060  0.48
2002 Bruce HA, Margolis RL. FOXP2: novel exons, splice variants, and CAG repeat length stability. Human Genetics. 111: 136-44. PMID 12189486 DOI: 10.1007/s00439-002-0768-5  0.48
2002 Margolis RL. The spinocerebellar ataxias: order emerges from chaos. Current Neurology and Neuroscience Reports. 2: 447-56. PMID 12169226  0.48
2002 Leroi I, O'Hearn E, Marsh L, Lyketsos CG, Rosenblatt A, Ross CA, Brandt J, Margolis RL. Psychopathology in patients with degenerative cerebellar diseases: a comparison to Huntington's disease. The American Journal of Psychiatry. 159: 1306-14. PMID 12153822 DOI: 10.1176/appi.ajp.159.8.1306  0.48
2002 Bauer I, Gencik M, Laccone F, Peters H, Weber BH, Feder EH, Weirich H, Morris-Rosendahl DJ, Rolfs A, Gencikova A, Bauer P, Wenning GK, Epplen JT, Holmes SE, Margolis RL, et al. Trinucleotide repeat expansions in the junctophilin-3 gene are not found in Caucasian patients with a Huntington's disease-like phenotype. Annals of Neurology. 51: 662. PMID 12112122 DOI: 10.1002/ana.10184  0.48
2002 Silveira I, Miranda C, Guimarães L, Moreira MC, Alonso I, Mendonça P, Ferro A, Pinto-Basto J, Coelho J, Ferreirinha F, Poirier J, Parreira E, Vale J, Januário C, Barbot C, ... ... Margolis RL, et al. Trinucleotide repeats in 202 families with ataxia: a small expanded (CAG)n allele at the SCA17 locus. Archives of Neurology. 59: 623-9. PMID 11939898  0.48
2002 Stevanin G, Camuzat A, Holmes SE, Julien C, Sahloul R, Dodé C, Hahn-Barma V, Ross CA, Margolis RL, Durr A, Brice A. CAG/CTG repeat expansions at the Huntington's disease-like 2 locus are rare in Huntington's disease patients. Neurology. 58: 965-7. PMID 11914418  0.48
2001 Holmes SE, Hearn EO, Ross CA, Margolis RL. SCA12: an unusual mutation leads to an unusual spinocerebellar ataxia. Brain Research Bulletin. 56: 397-403. PMID 11719278 DOI: 10.1016/S0361-9230(01)00596-2  0.48
2001 Holmes SE, O'Hearn E, Rosenblatt A, Callahan C, Hwang HS, Ingersoll-Ashworth RG, Fleisher A, Stevanin G, Brice A, Potter NT, Ross CA, Margolis RL. A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2. Nature Genetics. 29: 377-8. PMID 11694876 DOI: 10.1038/ng760  0.48
2001 Margolis RL, Ross CA. Expansion explosion: new clues to the pathogenesis of repeat expansion neurodegenerative diseases. Trends in Molecular Medicine. 7: 479-82. PMID 11689312 DOI: 10.1016/S1471-4914(01)02179-7  0.48
2001 Margolis RL, O'Hearn E, Rosenblatt A, Willour V, Holmes SE, Franz ML, Callahan C, Hwang HS, Troncoso JC, Ross CA. A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion. Annals of Neurology. 50: 373-80. PMID 11558794 DOI: 10.1002/ana.1124  0.48
2001 Rosenblatt A, Brinkman RR, Liang KY, Almqvist EW, Margolis RL, Huang CY, Sherr M, Franz ML, Abbott MH, Hayden MR, Ross CA. Familial influence on age of onset among siblings with Huntington disease. American Journal of Medical Genetics. 105: 399-403. PMID 11449389 DOI: 10.1002/ajmg.1400  0.48
2001 Fujigasaki H, Verma IC, Camuzat A, Margolis RL, Zander C, Lebre AS, Jamot L, Saxena R, Anand I, Holmes SE, Ross CA, Dürr A, Brice A. SCA12 is a rare locus for autosomal dominant cerebellar ataxia: a study of an Indian family. Annals of Neurology. 49: 117-21. PMID 11198281 DOI: 10.1002/1531-8249(200101)49:1<117::AID-ANA19>3.0.CO;2-G  0.48
2001 Holbert S, Denghien I, Kiechle T, Rosenblatt A, Wellington C, Hayden MR, Margolis RL, Ross CA, Dausset J, Ferrante RJ, Néri C. The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis. Proceedings of the National Academy of Sciences of the United States of America. 98: 1811-6. PMID 11172033 DOI: 10.1073/pnas.041566798  0.48
2001 O'Hearn E, Holmes SE, Calvert PC, Ross CA, Margolis RL. SCA-12: Tremor with cerebellar and cortical atrophy is associated with a CAG repeat expansion. Neurology. 56: 299-303. PMID 11171892  0.48
2001 Leroi I, O'Hearn E, Margolis RL. Psychiatric syndromes in cerebellar degeneration International Review of Psychiatry. 13: 323-329.  0.48
2001 Margolis RL. Cerebellum and psychiatry International Review of Psychiatry. 13: 229-231.  0.48
2000 Nasir J, Lafuente MJ, Duan K, Colomer V, Engelender S, Ingersoll R, Margolis RL, Ross CA, Hayden MR. Human huntingtin-associated protein (HAP-1) gene: genomic organisation and an intragenic polymorphism. Gene. 254: 181-7. PMID 10974549 DOI: 10.1016/S0378-1119(00)00269-9  0.48
2000 Engelender S, Wanner T, Kleiderlein JJ, Wakabayashi K, Tsuji S, Takahashi H, Ashworth R, Margolis RL, Ross CA. Organization of the human synphilin-1 gene, a candidate for Parkinson's disease. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 11: 763-6. PMID 10967135 DOI: 10.1007/s003350010123  0.48
2000 McInnis MG, Swift-Scanlanl T, Mahoney AT, Vincent J, Verheyen G, Lan TH, Oruc L, Riess O, Van Broeckhoven C, Chen H, Kennedy JL, MacKinnon DF, Margolis RL, Simpson SG, McMahon FJ, et al. Allelic distribution of CTG18.1 in Caucasian populations: association studies in bipolar disorder, schizophrenia, and ataxia. Molecular Psychiatry. 5: 439-42. PMID 10889556  0.48
1999 Schilling G, Wood JD, Duan K, Slunt HH, Gonzales V, Yamada M, Cooper JK, Margolis RL, Jenkins NA, Copeland NG, Takahashi H, Tsuji S, Price DL, Borchelt DR, Ross CA. Nuclear accumulation of truncated atrophin-1 fragments in a transgenic mouse model of DRPLA. Neuron. 24: 275-86. PMID 10677044 DOI: 10.1016/S0896-6273(00)80839-9  0.48
1999 Margolis RL, Ross CA. Genetics of childhood disorders: IX. Triplet repeat disorders. Journal of the American Academy of Child and Adolescent Psychiatry. 38: 1598-600. PMID 10596262 DOI: 10.1097/00004583-199912000-00023  0.48
1999 Holmes SE, O'Hearn EE, McInnis MG, Gorelick-Feldman DA, Kleiderlein JJ, Callahan C, Kwak NG, Ingersoll-Ashworth RG, Sherr M, Sumner AJ, Sharp AH, Ananth U, Seltzer WK, Boss MA, Vieria-Saecker AM, ... ... Margolis RL, et al. Expansion of a novel CAG trinucleotide repeat in the 5' region of PPP2R2B is associated with SCA12. Nature Genetics. 23: 391-2. PMID 10581021 DOI: 10.1038/70493  0.48
1999 Margolis RL, McInnis MG, Rosenblatt A, Ross CA. Trinucleotide repeat expansion and neuropsychiatric disease. Archives of General Psychiatry. 56: 1019-31. PMID 10565502 DOI: 10.1001/archpsyc.56.11.1019  0.48
1999 Sawa A, Wiegand GW, Cooper J, Margolis RL, Sharp AH, Lawler JF, Greenamyre JT, Snyder SH, Ross CA. Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nature Medicine. 5: 1194-8. PMID 10502825 DOI: 10.1038/13518  0.48
1999 Ross CA, Wood JD, Schilling G, Peters MF, Nucifora FC, Cooper JK, Sharp AH, Margolis RL, Borchelt DR. Polyglutamine pathogenesis. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 354: 1005-11. PMID 10434299 DOI: 10.1098/rstb.1999.0452  0.48
1999 McInnis MG, Breschel TS, Margolis RL, Chellis J, MacKinnon DF, McMahon FJ, Simpson SG, Lan TH, Chen H, Ross CA, DePaulo JR. Family-based association analysis of the hSKCa3 potassium channel gene in bipolar disorder. Molecular Psychiatry. 4: 217-9. PMID 10395209  0.48
1999 Engelender S, Kaminsky Z, Guo X, Sharp AH, Amaravi RK, Kleiderlein JJ, Margolis RL, Troncoso JC, Lanahan AA, Worley PF, Dawson VL, Dawson TM, Ross CA. Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions. Nature Genetics. 22: 110-4. PMID 10319874 DOI: 10.1038/8820  0.48
1999 Nasir J, Maclean A, Engelender S, Duan K, Margolis RL, Kleiderlein JJ, Ross CA, Hayden MR. Chromosomal localization of the Huntingtin associated protein (HAP-1) gene in mouse and humans with radiation hybrid and interspecific backcross mapping. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 10: 397-8. PMID 10087300 DOI: 10.1007/s003359901009  0.48
1999 Ellerby LM, Andrusiak RL, Wellington CL, Hackam AS, Propp SS, Wood JD, Sharp AH, Margolis RL, Ross CA, Salvesen GS, Hayden MR, Bredesen DE. Cleavage of atrophin-1 at caspase site aspartic acid 109 modulates cytotoxicity. The Journal of Biological Chemistry. 274: 8730-6. PMID 10085113 DOI: 10.1074/jbc.274.13.8730  0.48
1999 Margolis RL, Stine OC, Ward CM, Franz ML, Rosenblatt A, Callahan C, Sherr M, Ross CA, Potter NT. Unstable expansion of the CAG trinucleotide repeat in MAB21L1: report of a second pedigree and effect on protein expression. Journal of Medical Genetics. 36: 62-4. PMID 9950369  0.48
1999 Margolis RL, Stine OC, Callahan C, Rosenblatt A, Abbott MH, Sherr M, Ross CA. Two novel single-base-pair substitutions adjacent to the CAG repeat in the huntington disease gene (IT15): implications for diagnostic testing. American Journal of Human Genetics. 64: 323-6. PMID 9915978 DOI: 10.1086/302209  0.48
1998 Ross CA, Margolis RL, Becher MW, Wood JD, Engelender S, Cooper JK, Sharp AH. Pathogenesis of neurodegenerative diseases associated with expanded glutamine repeats: new answers, new questions. Progress in Brain Research. 117: 397-419. PMID 9932422  0.48
1998 Kleiderlein JJ, Nisson PE, Jessee J, Li WB, Becker KG, Derby ML, Ross CA, Margolis RL. CCG repeats in cDNAs from human brain. Human Genetics. 103: 666-73. PMID 9921901 DOI: 10.1007/s004390050889  0.48
1998 Rosenblatt A, Margolis RL, Becher MW, Aylward E, Franz ML, Sherr M, Abbott MH, Lian KY, Ross CA. Does CAG repeat number predict the rate of pathological changes in Huntington's disease? Annals of Neurology. 44: 708-9. PMID 9778276 DOI: 10.1002/ana.410440424  0.48
1998 Rosenblatt A, Ranen NG, Rubinsztein DC, Stine OC, Margolis RL, Wagster MV, Becher MW, Rosser AE, Leggo J, Hodges JR, ffrench-Constant CK, Sherr M, Franz ML, Abbott MH, Ross CA. Patients with features similar to Huntington's disease, without CAG expansion in huntingtin. Neurology. 51: 215-20. PMID 9674805  0.48
1998 Wood JD, Yuan J, Margolis RL, Colomer V, Duan K, Kushi J, Kaminsky Z, Kleiderlein JJ, Sharp AH, Ross CA. Atrophin-1, the DRPLA gene product, interacts with two families of WW domain-containing proteins. Molecular and Cellular Neurosciences. 11: 149-60. PMID 9647693 DOI: 10.1006/mcne.1998.0677  0.48
1998 Wellington CL, Ellerby LM, Hackam AS, Margolis RL, Trifiro MA, Singaraja R, McCutcheon K, Salvesen GS, Propp SS, Bromm M, Rowland KJ, Zhang T, Rasper D, Roy S, Thornberry N, et al. Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. The Journal of Biological Chemistry. 273: 9158-67. PMID 9535906 DOI: 10.1074/jbc.273.15.9158  0.48
1997 Ross CA, Margolis RL. Puzzles of psychiatric genetics--new candidate gene approaches. Molecular Psychiatry. 2: 432-3. PMID 9399680  0.48
1997 Ross CA, Margolis RL, Rosenblatt A, Ranen NG, Becher MW, Aylward E. Huntington disease and the related disorder, dentatorubral-pallidoluysian atrophy (DRPLA). Medicine. 76: 305-38. PMID 9352736 DOI: 10.1097/00005792-199709000-00001  0.48
1997 Breschel TS, McInnis MG, Margolis RL, Sirugo G, Corneliussen B, Simpson SG, McMahon FJ, MacKinnon DF, Xu JF, Pleasant N, Huo Y, Ashworth RG, Grundstrom C, Grundstrom T, Kidd KK, et al. A novel, heritable, expanding CTG repeat in an intron of the SEF2-1 gene on chromosome 18q21.1. Human Molecular Genetics. 6: 1855-63. PMID 9302263 DOI: 10.1093/hmg/6.11.1855  0.48
1997 Margolis RL, Abraham MR, Gatchell SB, Li SH, Kidwai AS, Breschel TS, Stine OC, Callahan C, McInnis MG, Ross CA. cDNAs with long CAG trinucleotide repeats from human brain. Human Genetics. 100: 114-22. PMID 9225980 DOI: 10.1007/s004390050476  0.48
1997 Alford RL, Margolis RL, Ross CA, Richards CS. Southern analysis for detection of CAG repeat expansions associated with dentatorubral pallidoluysian atrophy. Human Genetics. 99: 354-6. PMID 9050922 DOI: 10.1007/s004390050371  0.48
1996 Khan FA, Margolis RL, Loev SL, Sharp AH, Li SH, Ross CA. cDNA cloning and characterization of an atrophin-1 (DRPLA disease gene)-related protein. Neurobiology of Disease. 3: 121-8. PMID 9173919 DOI: 10.1006/nbdi.1996.0012  0.48
1996 Margolis RL, Li SH, Young WS, Wagster MV, Stine OC, Kidwai AS, Ashworth RG, Ross CA. DRPLA gene (atrophin-1) sequence and mRNA expression in human brain. Brain Research. Molecular Brain Research. 36: 219-26. PMID 8965642 DOI: 10.1016/0169-328X(95)00241-J  0.48
1996 Margolis RL, Stine OC, McInnis MG, Ranen NG, Rubinsztein DC, Leggo J, Brando LV, Kidwai AS, Loev SJ, Breschel TS, Callahan C, Simpson SG, DePaulo JR, McMahon FJ, Jain S, et al. cDNA cloning of a human homologue of the Caenorhabditis elegans cell fate-determining gene mab-21: expression, chromosomal localization and analysis of a highly polymorphic (CAG)n trinucleotide repeat. Human Molecular Genetics. 5: 607-16. PMID 8733127  0.48
1996 Margolis RL, Harrison SA, Robinson HJ, Jayaram G. Occupational therapy task observation scale (OTTOS): a rapid method for rating task group function of psychiatric patients. The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association. 50: 380-5. PMID 8728668  0.48
1996 Jain S, Leggo J, DeLisi LE, Crow TJ, Margolis RL, Li SH, Goodburn S, Walsh C, Paykel ES, Ferguson-Smith MA, Ross CA, Rubinsztein DC. Analysis of thirteen trinucleotide repeat loci as candidate genes for schizophrenia and bipolar affective disorder. American Journal of Medical Genetics. 67: 139-46. PMID 8723040 DOI: 10.1002/(SICI)1096-8628(19960409)67:2<139::AID-AJMG3>3.0.CO;2-N  0.48
1995 Loev SJ, Margolis RL, Young WS, Li SH, Schilling G, Ashworth RG, Ross CA. Cloning and expression of the rat atrophin-I (DRPLA disease gene) homologue. Neurobiology of Disease. 2: 129-38. PMID 9173996 DOI: 10.1006/nbdi.1995.0014  0.48
1995 Gao XM, Margolis RL, Leeds P, Hough C, Post RM, Chuang DM. Carbamazepine induction of apoptosis in cultured cerebellar neurons: effects of N-methyl-D-aspartate, aurintricarboxylic acid and cycloheximide. Brain Research. 703: 63-71. PMID 8719616 DOI: 10.1016/0006-8993(95)01066-1  0.48
1995 Margolis RL, Breschel TS, Li SH, Kidwai AS, Antonarakis SE, McInnis MG, Ross CA. Characterization of cDNA clones containing CCA trinucleotide repeats derived from human brain. Somatic Cell and Molecular Genetics. 21: 279-84. PMID 8525433 DOI: 10.1007/BF02255782  0.48
1995 Rubinsztein DC, Amos W, Leggo J, Goodburn S, Jain S, Li SH, Margolis RL, Ross CA, Ferguson-Smith MA. Microsatellite evolution--evidence for directionality and variation in rate between species. Nature Genetics. 10: 337-43. PMID 7670473 DOI: 10.1038/ng0795-337  0.48
1995 Margolis RL, Breschel TS, Li SH, Kidwai AS, McInnis MG, Ross CA. Polymorphic (AAT) in trinucleotide repeats derived from a human brain cDNA library. Human Genetics. 96: 495-6. PMID 7557981 DOI: 10.1007/BF00191817  0.48
1994 Margolis RL, Chuang DM, Post RM. Programmed cell death: implications for neuropsychiatric disorders. Biological Psychiatry. 35: 946-56. PMID 8080894  0.96
1993 Margolis RL, Chuang DM, Dick D, Weiss SR, Post RM. Effect of cocaine, lidocaine kindling and carbamazepine on batrachotoxin-induced phosphoinositide hydrolysis in rat brain slices. Brain Research. 614: 185-90. PMID 8394185 DOI: 10.1016/0006-8993(93)91033-O  0.48
1993 Li SH, Schilling G, Young WS, Li XJ, Margolis RL, Stine OC, Wagster MV, Abbott MH, Franz ML, Ranen NG. Huntington's disease gene (IT15) is widely expressed in human and rat tissues. Neuron. 11: 985-93. PMID 8240819 DOI: 10.1016/0896-6273(93)90127-D  0.48
1989 Margolis RL, Moran TH, McHugh PR. In vitro response of rat gastrointestinal segments to cholecystokinin and bombesin. Peptides. 10: 157-61. PMID 2748418 DOI: 10.1016/0196-9781(89)90092-2  0.48
Show low-probability matches.